HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, K. S. Articles by Sykes, B. D. Search for Related Content PubMed PubMed Citation Articles by Kim, K. S. Articles by Sykes, B. D. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 52, 32909-32915, 12, 1994

Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy

KS Kim, I Clark-Lewis and BD Sykes
Protein Engineering Network of Centres of Excellence (PENCE), University of Alberta, Edmonton, Canada.

The three-dimensional solution structure of the growth-related protein- alpha/melanoma growth stimulatory activity (GRO/MGSA) has been solved by two-dimensional 1H nuclear magnetic resonance spectroscopy. The GRO/MGSA monomer consists of an NH2-terminal loop, a three-stranded antiparallel beta-sheet, and a COOH-terminal alpha-helix. Dimerization, which is apparent under the experimental conditions used (2 mM, pH 5.10, 30 degrees C), results in a six-stranded antiparallel beta-sheet and a pair of helices with 2-fold symmetry. While the basic fold is similar to that seen for interleukin-8 (IL-8) (Clore, G. M., Appella, E., Yamada, M., Matsushima, K., and Gronenborn, A. M. (1990) Biochemistry, 29, 1689-1696), there are differences in the ELR motif (residues 6-8), the turn involving residues 31-36, which is linked to the NH2-terminal region through the 9-35 disulfide bond. The most significant differences are in the NH2-terminal loop (residues 12-23). In IL-8, all the corresponding regions have been shown to be required for receptor binding (Clark-Lewis, I., Dewald, B., Loetscher, M., Moser, B., and Baggiolini, M. (1994) J. Biol. Chem. 269, 16075-16081). The structural differences thus have been identified between GRO/MGSA and IL-8 could contribute to their different receptor binding specificities.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Gordon, F. Li, X. Zhang, W. Wang, X. Zhao, and A. Nayyar The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals J. Leukoc. Biol., December 1, 2005; 78(6): 1265 - 1272. [Abstract] [Full Text] [PDF]

				E. L. Malin, E. M. Brown, E. D. Wickham, and H. M. Farrell Jr. Contributions of Terminal Peptides to the Associative Behavior of {alpha}s1-Casein J Dairy Sci, July 1, 2005; 88(7): 2318 - 2328. [Abstract] [Full Text] [PDF]

				I. V. Nesmelova, Y. Sham, A. Z. Dudek, L. I. van Eijk, G. Wu, A. Slungaard, F. Mortari, A. W. Griffioen, and K. H. Mayo Platelet Factor 4 and Interleukin-8 CXC Chemokine Heterodimer Formation Modulates Function at the Quaternary Structural Level J. Biol. Chem., February 11, 2005; 280(6): 4948 - 4958. [Abstract] [Full Text] [PDF]

				L. Rajagopalan and K. Rajarathnam Ligand Selectivity and Affinity of Chemokine Receptor CXCR1: ROLE OF N-TERMINAL DOMAIN J. Biol. Chem., July 16, 2004; 279(29): 30000 - 30008. [Abstract] [Full Text] [PDF]

				F. Petersen, L. Bock, H.-D. Flad, and E. Brandt A Chondroitin Sulfate Proteoglycan on Human Neutrophils Specifically Binds Platelet Factor 4 and Is Involved in Cell Activation J. Immunol., October 15, 1998; 161(8): 4347 - 4355. [Abstract] [Full Text] [PDF]

				C. Dealwis, E. J. Fernandez, D. A. Thompson, R. J. Simon, M. A. Siani, and E. Lolis Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha , a potent ligand for the HIV-1 "fusin" coreceptor PNAS, June 9, 1998; 95(12): 6941 - 6946. [Abstract] [Full Text] [PDF]

				K. Rajarathnam, C. M. Kay, B. Dewald, M. Wolf, M. Baggiolini, I. Clark-Lewis, and B. D. Sykes Neutrophil-activating Peptide-2 and Melanoma Growth-stimulatory Activity Are Functional as Monomers for Neutrophil Activation J. Biol. Chem., January 17, 1997; 272(3): 1725 - 1729. [Abstract] [Full Text] [PDF]

				H. B. Lowman, P. H. Slagle, L. E. DeForge, C. M. Wirth, B. L. Gillece-Castro, J. H. Bourell, and W. J. Fairbrother Exchanging Interleukin-8 and Melanoma Growth-stimulating Activity Receptor Binding Specificities J. Biol. Chem., June 14, 1996; 271(24): 14344 - 14352. [Abstract] [Full Text] [PDF]

				G. Williams, N. Borkakoti, G. A. Bottomley, I. Cowan, A. G. Fallowfield, P. S. Jones, S. J. Kirtland, G. J. Price, and L. Price Mutagenesis Studies of Interleukin-8 J. Biol. Chem., April 19, 1996; 271(16): 9579 - 9586. [Abstract] [Full Text] [PDF]

				E. Guan, J. Wang, and M. A. Norcross Identification of Human Macrophage Inflammatory Proteins 1alpha and 1beta as a Native Secreted Heterodimer J. Biol. Chem., April 6, 2001; 276(15): 12404 - 12409. [Abstract] [Full Text] [PDF]

				J. M. Perez-Canadillas, A. Zaballos, J. Gutierrez, R. Varona, F. Roncal, J. P. Albar, G. Marquez, and M. Bruix NMR Solution Structure of Murine CCL20/MIP-3alpha , a Chemokine That Specifically Chemoattracts Immature Dendritic Cells and Lymphocytes through Its Highly Specific Interaction with the beta -Chemokine Receptor CCR6 J. Biol. Chem., July 20, 2001; 276(30): 28372 - 28379. [Abstract] [Full Text] [PDF]